- US-listed companies
- Profound Medical Corp.
- Balance sheet
Profound Medical Corp.PROF
Market cap
$231.11M
P/E ratio
| 2020/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash and cash equivalents | - | - | - | 55 |
| Total cash & short-term investments | - | - | - | 55 |
| Inventories | - | - | - | 6 |
| Total current assets | - | - | - | 69 |
| Property, plant and equipment, net | - | - | - | 0 |
| Total non-current assets | - | - | - | 1 |
| Total assets | 105 | 64 | 44 | 70 |
| Accounts payable | - | - | - | 1 |
| Long-term debt, current | - | - | - | 2 |
| Total current liabilities | - | - | - | 7 |
| Long-term debt, non-current | - | - | - | 3 |
| Total non-current liabilities | - | - | - | 3 |
| Total liabilities | 7 | 12 | 13 | 10 |
| Common stock and paid-in capital | - | - | - | 303 |
| Retained earnings | - | - | - | -245 |
| Stockholders' equity | - | - | - | 60 |
| Total debt | - | - | - | 5 |
| Net debt | - | - | - | -50 |
| D/E ratio (%) | - | - | - | 7.7 |